Biomatrica

📍 San Diego, United States🗓 Founded 2004👥 12 employees💰 Last funded 2011
Rare Biomarkers, Delivered Reliably preserving and delivering rare biomarkers and assays to the clinic. Our technology stabilizes and protects critical biological material without lyophilization or degradation. "​In every disease there is a latency period and in this stage if we are able to detect the disease we can go for treatment before it becomes lethal"​ Karly et al. We believe the best path to research, diagnose, and treat disease is putting information-rich tissue into an immediate state of suspended animation. Before tissue degrades, blood clots, or molecules begin to dissociate. The challenge? It has to be done without interfering in the assays or diagnostic tests. It must work in areas without refrigeration. And, it can’t be expensive. Our key products achieve this: successfully suspending biomarkers in blood, saliva, tissue, and other bodily fluids. But there is more to do. And while not everyone on the Biomatrica team is a researcher, everyone wants cures to come faster and does their part, be it in operations, shipping, or finance. If you want to find out more about biomarker preservation or our other preservation solutions, please reach out – we want to hear from you!
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2004
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Biomatrica?
Biomatrica has 1 investors on record on gritt.io and 1 late-stage investors.
When did Biomatrica last raise funding?
The most recent investment in Biomatrica recorded on gritt.io was in 2011.
When was Biomatrica founded?
Biomatrica was founded in 2004.
What industry is Biomatrica in?
Biomatrica operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Biomatrica based?
Biomatrica is headquartered in San Diego, United States.